Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis

Pamela R. de Santiago, Alejandro Blanco, Fernanda Morales, Katherine Marcelain, Olivier Harismendy, Marcela Sjöberg Herrera, Ricardo Armisén

Open source

DOI
10.1016/j.lfs.2020.118956
Published
2021-03
Container
Life Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lfs.2020.118956,
  title = {Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis},
  author = {Pamela R. de Santiago and Alejandro Blanco and Fernanda Morales and Katherine Marcelain and Olivier Harismendy and Marcela Sjöberg Herrera and Ricardo Armisén},
  year = {2021},
  journal = {Life Sciences},
  doi = {10.1016/j.lfs.2020.118956},
  url = {https://doi.org/10.1016/j.lfs.2020.118956}
}

RIS

TY  - JOUR
TI  - Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis
AU  - Pamela R. de Santiago
AU  - Alejandro Blanco
AU  - Fernanda Morales
AU  - Katherine Marcelain
AU  - Olivier Harismendy
AU  - Marcela Sjöberg Herrera
AU  - Ricardo Armisén
PY  - 2021
JO  - Life Sciences
DO  - 10.1016/j.lfs.2020.118956
UR  - https://doi.org/10.1016/j.lfs.2020.118956
ER  - 

APA

Santiago, P. R. D., Blanco, A., Morales, F., Marcelain, K., Harismendy, O., Herrera, M. S., & Armisén, R. (2021). Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis. Life Sciences. https://doi.org/10.1016/j.lfs.2020.118956

Source records